Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Services
1.2.2. Biospecimen
1.2.3. Biobanks
1.2.4. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Middle East Biobanks Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growth of personalized medicine and genomics
3.2.1.2. Increasing R&D in biotechnology and pharmaceuticals
3.2.2. Market restraint analysis
3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.2. Sustainability challenges for biobanks
3.2.2.3. Other challenges in biobanking specimens for research
3.3. Middle East Biobanks Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Middle East Biobanks Market: Product & Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Product & Services Market Share, 2024 & 2033
4.3. Product
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Biobank Equipment
4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.6.1. Biobanking & repository
4.6.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.2. Lab processing
4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.3. Qualification/ Validation
4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.4. Cold Chain Logistics
4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.5. Other Services
4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East Biobanks Market: Biospecimen Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biospecimen Market Share, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.3.1. Human Tissues
5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
5.3.2. Human Organs
5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3. Stem Cells
5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.2. Adult Stem Cells
5.3.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.3. Embryonic Stem Cells
5.3.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.4. IPS Cells
5.3.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.5. Other Stem Cells
5.3.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.4. Other biospecimens
5.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East Biobanks Market: Biobanks Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biobanks Market Share, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.3.1. Physical/Real biobanks
6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
6.3.1.2. Tissue Biobanks
6.3.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.3. Population based biobanks
6.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.4. Genetic (DNA/RNA)
6.3.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.5. Disease based biobanks
6.3.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Virtual biobanks
6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East Biobanks Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Application Market Share, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.3.1. Therapeutics
7.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.2. Drug discovery & clinical research
7.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.3. Clinical Diagnostics
7.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.4. Other Applications
7.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Middle East Biobanks Market: Regional Estimates & Trend Analysis
8.1. Country Market Dashboard
8.2. Country Market Share Analysis, 2024 & 2033
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. Middle East
8.4.1. Saudi Arabia
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. UAE
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Kuwait
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
8.4.4. Qatar
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
8.4.5. Oman
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
8.4.6. Rest of Middle East
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company overview
9.4.1.2. Financial Performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial Performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Qiagen
9.4.3.1. Company overview
9.4.3.2. Financial Performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Danaher Corporation
9.4.4.1. Company overview
9.4.4.2. Financial Performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Becton, Dickinson, and Company (BD)
9.4.5.1. Company overview
9.4.5.2. Financial Performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Taylor-Wharton
9.4.6.1. Company overview
9.4.6.2. Financial Performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Charles River Laboratories
9.4.7.1. Company overview
9.4.7.2. Financial Performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Lonza
9.4.8.1. Company overview
9.4.8.2. Financial Performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Stemcell Technologies
9.4.9.1. Company overview
9.4.9.2. Financial Performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Biovault Family
9.4.10.1. Company overview
9.4.10.2. Financial Performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Middle East biobanks market, by country, 2021-2033 (USD Million)
Table 3 Middle East biobanks market, by product & services, 2021-2033 (USD Million)
Table 4 Middle East biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 5 Middle East biobanks market, by biobanks, 2021-2033 (USD Million)
Table 6 Middle East biobanks market, by application, 2021-2033 (USD Million)
Table 7 Saudi Arabia biobanks market, by product & services, 2021-2033 (USD Million)
Table 8 Saudi Arabia biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 9 Saudi Arabia biobanks market, by biobanks, 2021-2033 (USD Million)
Table 10 Saudi Arabia biobanks market, by application, 2021-2033 (USD Million)
Table 11 UAE biobanks market, by product & services, 2021-2033 (USD Million)
Table 12 UAE biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 13 UAE biobanks market, by biobanks, 2021-2033 (USD Million)
Table 14 UAE biobanks market, by application, 2021-2033 (USD Million)
Table 15 Kuwait biobanks market, by product & services, 2021-2033 (USD Million)
Table 16 Kuwait biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 17 Kuwait biobanks market, by biobanks, 2021-2033 (USD Million)
Table 18 Kuwait biobanks market, by application, 2021-2033 (USD Million)
Table 19 Qatar biobanks market, by product & services, 2021-2033 (USD Million)
Table 20 Qatar biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 21 Qatar biobanks market, by biobanks, 2021-2033 (USD Million)
Table 22 Qatar biobanks market, by application, 2021-2033 (USD Million)
Table 23 Oman biobanks market, by product & services, 2021-2033 (USD Million)
Table 24 Oman biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 25 Oman biobanks market, by biobanks, 2021-2033 (USD Million)
Table 26 Oman biobanks market, by application, 2021-2033 (USD Million)
Table 27 Rest of Middle East biobanks market, by product & services, 2021-2033 (USD Million)
Table 28 Rest of Middle East biobanks market, by biospecimen, 2021-2033 (USD Million)
Table 29 Rest of Middle East biobanks market, by biobanks, 2021-2033 (USD Million)
Table 30 Rest of Middle East biobanks market, by application, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Middle East Biobanks market: market outlook
Figure 9 Middle East Biobanks competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Middle East Biobanks market driver impact
Figure 15 Middle East Biobanks market restraint impact
Figure 16 Middle East Biobanks market strategic initiatives analysis
Figure 17 Middle East Biobanks market: Product & services movement analysis
Figure 18 Middle East Biobanks market: Product & services outlook and key takeaways
Figure 19 Product market estimates and forecast, 2021-2033
Figure 20 Biobanking equipment market estimates and forecast, 2021-2033
Figure 21 Temperature control systems estimates and forecast, 2021-2033
Figure 22 Freezers & refrigerators market estimates and forecast, 2021-2033
Figure 23 Cryogenic storage systems market estimates and forecast, 2021-2033
Figure 24 Thawing equipment market estimates and forecast, 2021-2033
Figure 25 Incubators & centrifuges market estimates and forecast, 2021-2033
Figure 26 Alarms & monitoring systems market estimates and forecast, 2021-2033
Figure 27 Accessories & other equipment market estimates and forecast, 2021-2033
Figure 28 Biobanking consumables market estimates and forecast, 2021-2033
Figure 29 Laboratory information management systems market estimates and forecast, 2021-2033
Figure 30 Services market estimates and forecasts, 2021-2033
Figure 31 Biobanking & repository market estimates and forecasts, 2021-2033
Figure 32 Lab processing market estimates and forecasts,2021-2033
Figure 33 Qualification/ Validation market estimates and forecasts,2021-2033
Figure 34 Cold chain logistics market estimates and forecasts, 2021-2033
Figure 35 Other services market estimates and forecasts,2021-2033
Figure 36 Middle East Biobanks market: Biospecimen movement analysis
Figure 37 Middle East Biobanks market: Biospecimen outlook and key takeaways
Figure 38 Human tissues market estimates and forecasts, 2021-2033
Figure 39 Human organs market estimates and forecasts,2021-2033
Figure 40 Stem cells market estimates and forecasts, 2021-2033
Figure 41 Adult stem cells market estimates and forecasts,2021-2033
Figure 42 Embryonic stem cells market estimates and forecasts, 2021-2033
Figure 43 IPS cells market estimates and forecasts, 2021-2033
Figure 44 Other stem cells market estimates and forecasts, 2021-2033
Figure 45 Other biospecimens market estimates and forecasts, 2021-2033
Figure 46 Middle East Biobanks market: Biobanks movement analysis
Figure 47 Middle East Biobanks market: Biobanks outlook and key takeaways
Figure 48 Physical/Real biobanks market estimates and forecasts, 2021-2033
Figure 49 Tissue biobanks market estimates and forecasts,2021-2033
Figure 50 Population based biobanks market estimates and forecasts, 2021-2033
Figure 51 Genetic (DNA/RNA) market estimates and forecasts,2021-2033
Figure 52 Disease based biobanks market estimates and forecasts, 2021-2033
Figure 53 Virtual biobanks market estimates and forecasts, 2021-2033
Figure 54 Middle East Biobanks market: Application movement analysis
Figure 55 Middle East Biobanks market: Application outlook and key takeaways
Figure 56 Therapeutics market estimates and forecasts, 2021-2033
Figure 57 Drug discovery & clinical research market estimates and forecasts,2021-2033
Figure 58 Clinical diagnostics market estimates and forecasts, 2021-2033
Figure 59 Other applications market estimates and forecasts,2021-2033
Figure 60 Middle East Biobanks market: Country movement analysis
Figure 61 Middle East Biobanks market: Country outlook and key takeaways
Figure 62 Saudi Arabia country dynamics
Figure 63 Saudi Arabia market estimates and forecasts, 2021-2033
Figure 64 UAE country dynamics
Figure 65 UAE market estimates and forecasts, 2021-2033
Figure 66 Kuwait country dynamics
Figure 67 Oman market estimates and forecasts, 2021-2033 Kuwait country dynamics
Figure 68 Oman market estimates and forecasts, 2021-2033
Figure 69 Qatar country dynamics
Figure 70 Qatar market estimates and forecasts, 2021-2033
Figure 71 Rest of Middle East country dynamics
Figure 72 Rest of Middle East market estimates and forecasts, 2021-2033
Figure 73 Market position of key market players- Middle East Biobanks market
